Clinical Trial Update: T Regulatory Lymphocytes (Treg) Depletion for Cancer Treatment Efficacy and Safety Study [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating depletion of regulatory T cells for cancer treatment efficacy and safety in colorectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Colorectal Cancer | Phase 1, Phase 2 | Status: COMPLETED